Skip To Content

ACD/Labs Blog

Novartis employs a variety of ACD/Labs software in support of structure elucidation and structure verification in pharmaceutical development and post-commercialization. Here they present: Their workflow for structure identification and elucidation for impurities and degradants Time-savings from automated structure verification—a system supporting research chemists for several years The importance of integrated, centralized data management in impurity...

Pharmaceutical development is data intensive. Chemical, analytical, and process information are necessary for route planning, impurity control, and regulatory documentation. Consolidating this data can be time-consuming, error-prone, and frustrating. How can pharmaceutical development scientists seamlessly access their results and make decisions? Watch this webinar where Dr. Hannah Davies (Principal Scientist, Pfizer) explains how Pfizer is...

Excel plays a critical role in research and development. Everyone from undergraduate students to elite pharmaceutical chemists relies on the program to process, analyze, and store their data. Unfortunately, spreadsheets are not designed to work with chemical information or support collaborative workflows. What’s the alternative? Season 3 of the Analytical Wavelength brings unique perspectives from...

Presented at ACD/Labs Paris Symposium 2022 Learn how ACD/Labs software is used in R&D labs like yours to effectively digitize and manage analytical data, and increase efficiency. Discover solutions that bring real benefits to scientists in various industries: Pharmaceutical, Chemical, AgroSciences, and various activities: R&D, analysis laboratory, Data Scientists etc.

N-nitrosamines are a growing challenge in pharmaceutical development. This class of mutagenic impurity has been responsible for multiple rounds of recalls that have hit several major pharmaceutical companies. Watch Joe DiMartino, the Luminata Solutions Manager present on “Using CMC Decision Support to Enhance Control Strategies” at the Scientific Update N-Nitrosamines Event. Topics include: Developing a data-driven...

This presentation provides an overview of the current state of research into N-nitrosamine impurities; what have we learned from systematic risk assessment, and what comes next.